1. Dr. Harvey F. Lodish, Professor of Biology and Biological Engineering, MIT;
2. Dr. Raju Kucherlapati, Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School;
3. Dr. Kipp Weiskopf, Fellow at Whitehead Institute;
4. Dr. Novalia Pishesha, Assistant Professor in the Division of Immunology at Boston Children’s Hospital and Harvard Medical School;
5. Jeanne LeClair, Vice President of Economic Development and Partnerships, Massachusetts Life Sciences Center;
6. Dr. Sean Cao, Operating Partner, CBC Group;
7. Dr. Jianzhu Chen, Professor of Biology, MIT and Intramural Faculty of Koch Institute for Integrative Cancer Research;
8. Dr. Weiyong Sun, Chief Business Officer, Hansoh Pharmaceutical Group;
9. Daniel Blanchard, Chair of Corporate Practice Group, Morse Law;
10. Dr. Yu Cao, Professor of Miner School of Computer & Information Science, UMass Lowell and Director of UMass Center for Digital Health;
11. Dr. Jing-Ke Weng, Inaugural Director of Institute for Plant-Human Interface (IPHI) and Professor of Chemistry, Chemical Biology, and Bioengineering, Northeastern University;
12. Dr. Ying Gong, Chief Business Officer, GV20 Therapeutics;
13. Dr. Frank W. An, VP of Institute of Biologics, the antibody discovery division, Biocytogen;
14. Dr. James Sun, VP of Bioinformatics, Harbinger Health.
